1y return+52.0%S&P 500 +20.9%
3y return+88.6%S&P 500 +68.5%
5y return+74.1%S&P 500 +74.5%
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
$100 invested in its stock picks
Since December 31, 2017: $363 against $280 in the S&P 500.2
Eversept Partners, LPS&P 500 (SPY)
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| UTHRUnited Therapeutics Corp Del | $155.9M | 8.5% | +8.9% |
| ABVXAbivax Sa | $121.8M | 6.6% | −2.2% |
| EHCEncompass Health Corp | $103.8M | 5.7% | +429.1% |
| ENSGEnsign Group Inc | $96.5M | 5.3% | +3978.8% |
| VERAVera Therapeutics Inc | $94.9M | 5.2% | +1.8% |
| CLDXCelldex Therapeutics Inc New | $66.5M | 3.6% | |
| SNDXSyndax Pharmaceuticals Inc | $61.2M | 3.3% | −3.0% |
| BKDBrookdale Sr Living Inc | $54.6M | 3.0% | −4.8% |
| IONSIonis Pharmaceuticals Inc | $52.7M | 2.9% | +5.2% |
| NTRANatera Inc | $47.7M | 2.6% | −54.3% |
| TVTXTravere Therapeutics Inc | $45.4M | 2.5% | +47.2% |
| CTRECaretrust Reit Inc | $43.3M | 2.4% | New |
| HCAHca Healthcare Inc | $38.3M | 2.1% | +24.0% |
| PCVXVaxcyte Inc | $36.6M | 2.0% | −31.8% |
| LQDALiquidia Corporation | $34.2M | 1.9% | −36.7% |
| CYHCommunity Health Sys Inc New | $26.3M | 1.4% | −9.4% |
| GSKGsk PLC | $25.3M | 1.4% | −73.0% |
| CHEChemed Corp New | $24.5M | 1.3% | +69.1% |
| LLYEli Lilly & Co | $24.1M | 1.3% | +5.9% |
| GERNGeron Corp | $24.0M | 1.3% | |
| VKTXViking Therapeutics Inc | $23.5M | 1.3% | +152.2% |
| OHIOmega Healthcare Invs Inc | $23.1M | 1.3% | −17.4% |
| PODDInsulet Corp | $22.7M | 1.2% | +3.7% |
| THCTenet Healthcare Corp | $21.4M | 1.2% | +287.0% |
| UNHUnitedhealth Group Inc | $21.3M | 1.2% | New |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| LQDALiquidia Corporation | March 31, 2021 | +2864.0% | $34.2M |
| NTRANatera Inc | June 30, 2022 | +666.0% | $47.7M |
| TVTXTravere Therapeutics Inc | March 31, 2024 | +636.8% | $45.4M |
| UTHRUnited Therapeutics Corp Del | June 30, 2020 | +347.8% | $155.9M |
| VERAVera Therapeutics Inc | September 30, 2022 | +101.4% | $94.9M |
| IONSIonis Pharmaceuticals Inc | June 30, 2021 | +98.8% | $52.7M |
| GSKGsk PLC | September 30, 2022 | +78.1% | $25.3M |
| ABVXAbivax Sa | September 30, 2025 | +57.0% | $121.8M |
| BKDBrookdale Sr Living Inc | December 31, 2025 | +49.1% | $54.6M |
| HCAHca Healthcare Inc | March 31, 2023 | +47.9% | $38.3M |
Sold off last quarter
- DOCHealthpeak Properties Inc was $32.5M
- AVTRAvantor Inc was $23.3M
- Qiagen NvCUSIP N72482156 was $21.8M
- Icon PLCCUSIP G4705A100 was $7.6M
- AGIOAgios Pharmaceuticals Inc was $6.8M
- MDGLMadrigal Pharmaceuticals Inc was $5.2M
- Esperion Therapeutics Inc NeCUSIP 29664W105 was $4.8M
- HQYHealthequity Inc was $4.3M
- Day One Biopharmaceuticals ICUSIP 23954D109 was $3.9M
- CNCCentene Corp Del was $3.7M
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +11.7% | +14.8% |
| March 31, 2026 | −3.9% | −4.6% |
| December 31, 2025 | +24.1% | +2.4% |
| September 30, 2025 | +14.1% | +7.8% |
| June 30, 2025 | +2.6% | +10.5% |
| March 31, 2025 | −8.8% | −4.6% |
| December 31, 2024 | −8.7% | +2.1% |
| September 30, 2024 | +14.3% | +5.4% |
| June 30, 2024 | −1.0% | +4.0% |
| March 31, 2024 | +22.5% | +10.0% |
| December 31, 2023 | +12.4% | +11.2% |
| September 30, 2023 | −6.9% | −3.6% |
| June 30, 2023 | −1.4% | +8.3% |
| March 31, 2023 | +2.9% | +7.0% |
| December 31, 2022 | +19.3% | +7.1% |
| September 30, 2022 | −7.9% | −5.3% |
| June 30, 2022 | −11.9% | −16.5% |
| March 31, 2022 | −6.9% | −4.9% |
| December 31, 2021 | −0.2% | +10.7% |
| September 30, 2021 | +1.1% | +0.3% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Eversept Partners, LP Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1697013&type=13F-HR&dateb=&owner=include&count=40CIK 1697013
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1697013/000169701326000005/Filed August 14, 2026 · accession 0001697013-26-000005